Navigation Links
Salmeterol - to be used in combination & only when required

Asthma experts at University of Iowa are taking efforts to make sure that an asthma drug combination is prescribed only when really needed.//

Salmeterol is a long-acting asthma drug that is used in combination with a corticosteroid, which is inhaled. The use of this combination can deteriorate the asthma for a few people with that condition.

The UI physicians reported two cases representing the few patients for whom the combination can make asthma more severe or even fatal in a letter published in the Aug. 24 issue of the New England Journal of Medicine (NEJM).

"For most patients whose asthma cannot be controlled with a low-dose inhaled steroid, adding salmeterol to the steroid provides increased benefits. So there's no question this can be a useful combination drug for many individuals," said Miles Weinberger, M.D., professor of pediatrics in the University of Iowa Roy J. and Lucille A. Carver College of Medicine.

"However, some patients are receiving the combination drug but don't actually need it, and there is at least a small subgroup of patients for whom previous research showed the salmeterol-steroid combination has a very negative, rather than beneficial, effect," said Weinberger, who also directs the UI Division of Pediatric Allergy and Pulmonary Diseases.

Advair, made by GlaxoSmithKine, contains salmeterol in addition to an inhaled corticosteroid and is extensively marketed, Weinberger said. It is one of the most commonly prescribed maintenance asthma medications in the United States and is meant to be used by patients on a regular, preventive basis, not to treat sudden asthma attacks.

"We do not want to unduly alarm people, but instead help spread the word that patients should talk with their physicians if they are using Advair, or another inhaled asthma medication that contains salmeterol and feel that it worsens symptoms instead of making them better," Weinberger said.

The UI physician
'"/>




Page: 1 2 3

Related medicine news :

1. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
2. The bad combination
3. Warding off symptoms of premenstrual syndrome by combination therapy
4. Cholesterol can be lowered using combination of Soy Proteins and Sterols
5. Nanocells cancer combination therapy acts as chemotherapy as well as anti-angiogenic drug
6. Calcitriol [Vitamin D] with combination of painkillers for cancer treatment
7. Chloroquine and Primaquine combination Malarial drug for resistant parasites.
8. Eloxatin combination reduces bowel cancer recurrences
9. Death from heart attack can be reduced by new drug combination
10. New tetanus-diphtheria combination vaccine launched by Serum Institute of India
11. More effective Antiretroviral HIV drug combination

Post Your Comments:
(Date:12/3/2009)...n, DC The study of tobacco has been the life-long... deputy director of the Lombardi Comprehensive Can..., has led the effort to edit a special-edition of ...EBP ) dedicated to best research practices in toba...he December issue of CEBP , a journal of the Amer...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Reportlink... is available in its catalogue: ,, Renal Disea...://www.reportlinker.com/p0166824/Renal-Disease-Tre...ts for the U.S. market in products and services, p... projections for the market and compound annual gr...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Reportlink... is available in its catalogue: ,, Antibiotic ...kets ,, http://www.reportlinker.com/p0166825/...Global-Markets.html ,, Provide an in-depth rev...e and antibiotics technologies ,, Offer an anal...
(Date:12/2/2009)...ovement seen for advanced cases, study finds , ...the past two decades, survival rates for advanced ...roved modestly, a new study has found. , Resear...diagnosed with stage 4 non-small cell lung cancer ...tion was in the U.S. National Cancer Institute,s S...
(Date:12/2/2009)...ecially likely to have metabolic syndrome, study f...ws) -- Exercise alone isn,t enough to keep overwei...risk for a medical condition that can lead to hear...studied linemen at Division I colleges and found t...d metabolic syndrome, a group of conditions that r...
Breaking Medicine News(10 mins):Health News:Lombardi's Shields leads special journal focused on tobacco research 2Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 2Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 3Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 4Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 5Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 6Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 7Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 8Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 9Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 10Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 2Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 3Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 4Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 5Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 6Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 7Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 8Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 9Health News:Gains Made in Lung Cancer Survival 2Health News:Oversized College Football Players May Face Heart Risks 2
...earch activities under a common umbrella, Orchid C...buyout US-based Bexel Pharmaceuticals Inc by acqui... (three million dollars). The company holds a...ies to bring the drug discovery activities under a...
...orted to have spread in about 26 districts in Maha...he disease is not fatal it weakens the immune syst...was first reported in Tasmania. Maharashtra state ... steps to prevent and protect themselves against t...
... light up the lives of thousands of cancer patient...e kidney and the gut.// Initial examinations of th...t, lung and pancreatic cancers. This drug c...cancers. Further Sutent ensures that tumors run dr...
... won’t only make you age slowly, but as A new rese... will help keep the weight down and maintain good ...ssor Peter Howe, from the University of South Aust...ontaining Omega-3 fatty acids, along with moderate...
...reated with honey than with most modern antibiotic...s conducted by researchers from the University of ...m Homburg, Düsseldorf and Berlin and they found th... within a few weeks. According to Dr Arne Simo...
...cience University study has demonstrated that moti...sist in keeping// a tab on the pattern of activity... initial signs of onset of dementia. The study res...shed that consistent and non-interfering monitorin...
Other Medicine News:Health News:Fatty Acids In Fish Oil Helps Fight Obesity 2Health News:Sensors placed at home capable of signaling onset of early signs of dementia in elderly 2Health News:Sensors placed at home capable of signaling onset of early signs of dementia in elderly 3
(Date:12/2/2009)... TAMPA, Fla., Dec. 2 Laser Spine ... spinal surgery, is pleased to announce a partner...an extensive six-month negotiation and clinical re... healthcare provider of minimally invasive spinal ...ffective immediately, patients with United Healthc...
(Date:12/2/2009)... , LAKE FOREST, Ill., Dec. 2 /PRNewswire-FirstC...ovider of clinical information and medication deli...uired Salt Lake City-based TheraDoc, a clinical in...nce systems. TheraDoc,s two leading products, Infe...nt(TM), join Hospira,s expanding portfolio of medi...
(Date:12/2/2009)..., WALTHAM, Mass. and NEW YORK, Dec. 2 /PRNewswire...ex: ILI ) and NYU Langone Medical Center announce... with Duke University on the genetics of osteoarth... First" version of the Annals of Rheumatic Disease...dpdf/ard.2009.113043v1.pdf . Results from the ...
Breaking Medicine Technology:Laser Spine Institute Partners with United Healthcare 2Laser Spine Institute Partners with United Healthcare 3Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings 2Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings 3Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings 4Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management Offerings 5Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 2Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 3Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 4Could Your Family Be The Family of the Year 3F 54093 1Could Your Family Be The Family of the Year 3F 54093 2Could Your Family Be The Family of the Year 3F 54093 3Could Your Family Be The Family of the Year 3F 54093 4Could Your Family Be The Family of the Year 3F 54093 5American College of Chest Physicians Names New CEO 54090 1American College of Chest Physicians Names New CEO 54090 2US State Department Brings Foreign Journalists to Hear About Drug Prevention Efforts in Georgia 54085 1US State Department Brings Foreign Journalists to Hear About Drug Prevention Efforts in Georgia 54085 2
...6 TargeGen, Inc. today announced that,the Company...ve and the,Company plans to initiate a multi-cente...ered, oral, potent, and highly selective JAK2 inhi...ounced that a series of,presentations related to T...tlanta, December 8-11, 2007) by Company scientific...
...SCO, Calif., Dec. 6 Rigel,Pharmaceuticals, Inc. (...,partner, Pfizer (NYSE: PFE ), has begun a Phase ...l,s small molecule syk kinase inhibitor, R343,for ...d product candidate,in Rigel,s clinical portfolio....ation agreement, Rigel,will receive a $5 million m...
Other Medicine Technology:TargeGen Announces Planned Initiation of Clinical Trial of JAK2 Inhibitor TG101348 in Myeloproliferative Disease Patients, and Presentations at ASH 2Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer 2Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer 3
Fascial Incising Needles
Mitty-Pollack Needle Set - Standard
Light Guide Cables - 2.0mm
3mm Universal Light Guide
Medicine Products: